Alternative Splicing of Bcap (PIK3AP1) Enhances Oncogenic Signaling in Subsets of Activated B-Cell Diffuse Large B-Cell Lymphoma

被引：0
|
作者：
Itsara, Andy [1 ]
Scheich, Sebastian [2 ]
Haeupl, Bjoern [3 ,4 ,5 ,6 ]
Yu, Xin [2 ]
Oellerich, Thomas [3 ,4 ,5 ,6 ]
Staudt, Louis M. [2 ]
机构：
[1] NHLBI, Hematol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA
[2] NCI, Lymphoid Malignancies Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[3] German Canc Res Ctr, Heidelberg, Germany
[4] German Canc Consortium, Heidelberg, Germany
[5] Goethe Univ, Dept Med 2, Hematol Oncol, Frankfurt, Germany
[6] Goethe Univ, Frankfurt Canc Inst, Frankfurt, Germany
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-163619
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：6394 / 6395
页数：2
相关论文
共 50 条
  • [1] DETAILED IMMUNOPHENOTYPING OF B-CELL SUBSETS IN DIFFUSE LARGE B-CELL LYMPHOMA
    Talaulikar, Dipti
    Ziolkowski, Andrew
    Jain, Sanjiv
    Vohra, Harpreet
    Tobin, Josh
    Cook, Matthew
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2013, 84 (06) : 423 - 423
  • [2] B-Cell Receptor Signaling in Diffuse Large B-Cell lymphoma
    Young, Ryan M.
    Shaffer, Arthur L., III
    Phelan, James D.
    Staudt, Louis M.
    SEMINARS IN HEMATOLOGY, 2015, 52 (02) : 77 - 85
  • [3] Tonic B-cell receptor signaling in diffuse large B-cell lymphoma
    Havranek, Ondrej
    Xu, Jingda
    Koehrer, Stefan
    Wang, Zhiqiang
    Becker, Lisa
    Comer, Justin M.
    Henderson, Jared
    Ma, Wencai
    Ma, John Man Chun
    Westin, Jason R.
    Ghosh, Dipanjan
    Shinners, Nicholas
    Sun, Luhong
    Yi, Allen F.
    Karri, Anusha R.
    Burger, Jan A.
    Zal, Tomasz
    Davis, R. Eric
    BLOOD, 2017, 130 (08) : 995 - 1006
  • [4] Survival associated alternative splicing events in diffuse large B-cell lymphoma
    Zhang, Rui
    Lin, Peng
    Yang, Xia
    He, Rong Qian
    Wu, Hua-Yu
    Dang, Yi-Wu
    Gu, Yong-Yao
    Peng, Zhi-Gang
    Feng, Zhen-Bo
    Chen, Gang
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2018, 10 (08): : 2636 - 2647
  • [5] Diffuse large B-cell lymphoma - Molecular heterogeneity of diffuse large B-cell lymphoma
    Gascoyne, RD
    HEMATOLOGY JOURNAL, 2004, 5 : S144 - S148
  • [6] Dasatinib Is Preferentially Active in the Activated B-Cell Subtype of Diffuse Large B-Cell Lymphoma
    Cann, Marissa L.
    Herring, Laura E.
    Haar, Lauren L.
    Gilbert, Thomas S. K.
    Goldfarb, Dennis
    Richards, Kristy L.
    Graves, Lee M.
    Lawrence, David S.
    JOURNAL OF PROTEOME RESEARCH, 2019, 18 (01) : 522 - 534
  • [7] B-Cell Receptor Signaling Modulates Cholesterol Biosynthesis in Diffuse Large B-Cell Lymphoma
    Agarwal, Nitin
    Aradhya, Akanksha
    Marques-Piubelli, Mario L.
    Soto, Luisa M. Solis
    Bilbao, Daniel
    Landgraf, Ralf
    Ravanmehr, Vida
    Henderson, Jared
    Green, Michael R.
    Davis, Eric
    Vega, Francisco
    BLOOD, 2022, 140 : 1320 - 1321
  • [8] Targeting B-cell receptor and PI3K signaling in diffuse large B-cell lymphoma
    Xu, Wendan
    Berning, Philipp
    Lenz, Georg
    BLOOD, 2021, 138 (13) : 1110 - 1119
  • [9] Diffuse large B-cell lymphoma
    Barraclough, Allison
    Hawkes, Eliza
    Sehn, Laurie H.
    Smith, Sonali M.
    HEMATOLOGICAL ONCOLOGY, 2024, 42 (06)
  • [10] Diffuse Large B-Cell Lymphoma
    Sehn, Laurie H.
    Salles, Gilles
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (09): : 842 - 858
12345